Search results
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 7 minutes agoSen. Bernie Sanders blasted the Danish drugmaker Novo Nordisk this week for charging U.S. residents...
Here’s why a Florida company recalled its male sexual enhancement drugs sold on Amazon
Miami Herald via Yahoo News· 10 minutes ago“People with diabetes, high blood pressure, high cholesterol, or heart disease often...
Cancer drugs help drive AstraZeneca sales sharply higher
PA Media: Money via Yahoo Finance· 26 minutes agoPascal Soriot, chief executive of the company, said it “had a very strong start in 2024”. It...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 23 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 3 hours agoThe pharmaceutical giant also raised and narrowed its full-year revenue and adjusted earnings...
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the...
WLNS Lansing· 6 hours agoMedivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via Yahoo Finance· 3 hours ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of...
McKinsey advised drug companies on how to 'turbocharge' opioid sales. Now it's under criminal...
INSIDER via Yahoo News· 9 hours agoThe firm has previously paid nearly $1 billion to resolve lawsuits related to its opioid work. The...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 2 hours agoThe New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its...
For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
The Wall Street Journal· 2 hours agoSales dropped yet again to $2.29 billion, missing Wall Street estimates. The company’s multiple...